Kamil Jonczyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kamil Jonczyk has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Janczura
Faculty of Medicine, Jan Kochanowski University, Kielce, Poland
3 shared publications - Krzysztof Łupina
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2 shared publications - Paulina Jaskulska
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2 shared publications - Piotr Starnawski
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2 shared publications - Weronika Stępień
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2 shared publications - Adrian Nowak
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
1 shared publication
Latest Publications
- 16 September 2026
- Published by Springer Nature in Calcified Tissue International
- Vol. 117 (1) , 143
The Liver-Bone Axis in Steatotic Liver Disease
- 16 September 2026
- Published by Springer Nature in Calcified Tissue International
- Vol. 117 (1) , 143
The Liver-Bone Axis in Steatotic Liver Disease
- Open Access
- 12 May 2026
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
Unusual presentation of small bowel obstruction in Cowden syndrome: A case report and literature review
Intestinal intussusception in adults is a rare disorder, occurring in about 5% of cases. In the pediatric population, it is most often idiopathic in origin, while in adults it is associated with pathologies within the intestinal wall. The purpose of this study is to emphasize the need for expanded diagnosis in adult patients with symptoms of gastrointestinal obstruction due to intestinal intussusception. The medical records of a 22-year-old female patient hospitalized in the Department of General Surgery of St. Alexander Hospital in Kielce were analyzed. The patient presented to the hospital with complaints of abdominal pain accompanied by vomiting. She had a history of treatment for Hashimoto’s disease, iron deficiency anemia and gastritis. After initial diagnosis, the patient was transferred to the department of general surgery, where conservative treatment was implemented and gastroscopy was performed. During hospitalization, the patient was consulted in internal medicine due to uncompensated hypothyroidism. Due to lack of improvement, imaging studies were ordered, which revealed a dilated loop of small intestine with suspected intussusception. The patient was qualified for surgery, during which an intussusception of the jejunum was found. Due to the inability to drain the intussusception, a segmental small bowel resection was performed. Histopathological examination revealed a hamartomatous polyp as the cause of the intussusception. Given the overall clinical picture, the patient was referred to the genetic counseling center, where Cowden syndrome was confirmed. Intestinal intussusception, although rare, should be considered as a cause of gastrointestinal obstruction in adults. Identification of the pathological changes that are its cause is crucial to the overall diagnostic and therapeutic process.
- 12 May 2026
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
Open AccessUnusual presentation of small bowel obstruction in Cowden syndrome: A case report and literature review
Intestinal intussusception in adults is a rare disorder, occurring in about 5% of cases. In the pediatric population, it is most often idiopathic in origin, while in adults it is associated with pathologies within the intestinal wall. The purpose of this study is to emphasize the need for expanded diagnosis in adult patients with symptoms of gastrointestinal obstruction due to intestinal intussusception. The medical records of a 22-year-old female patient hospitalized in the Department of General Surgery of St. Alexander Hospital in Kielce were analyzed. The patient presented to the hospital with complaints of abdominal pain accompanied by vomiting. She had a history of treatment for Hashimoto’s disease, iron deficiency anemia and gastritis. After initial diagnosis, the patient was transferred to the department of general surgery, where conservative treatment was implemented and gastroscopy was performed. During hospitalization, the patient was consulted in internal medicine due to uncompensated hypothyroidism. Due to lack of improvement, imaging studies were ordered, which revealed a dilated loop of small intestine with suspected intussusception. The patient was qualified for surgery, during which an intussusception of the jejunum was found. Due to the inability to drain the intussusception, a segmental small bowel resection was performed. Histopathological examination revealed a hamartomatous polyp as the cause of the intussusception. Given the overall clinical picture, the patient was referred to the genetic counseling center, where Cowden syndrome was confirmed. Intestinal intussusception, although rare, should be considered as a cause of gastrointestinal obstruction in adults. Identification of the pathological changes that are its cause is crucial to the overall diagnostic and therapeutic process.
- 24 June 2025
- Published by Index Copernicus in Medical Science Pulse
Environmental and socioeconomic factors influencing hepatotropic virus transmission
Background: Viral hepatitis remains a major public health concern worldwide. In 2022 alone, it accounted for approximately 1.3 million deaths, with hepatitis B (HBV) and hepatitis C viruses (HCV) responsible for the majority. However, hepatitis A (HAV) and hepatitis E (HEV) viruses continue to cause significant outbreaks, especially in settings with poor sanitation, while hepatitis D virus contributes to more severe outcomes in individuals with HBV. The burden of these infections is disproportionately high in low- and middle-income countries, where socioeconomic disparities, environmental conditions, and healthcare limitations hinder prevention and control efforts. Aims of the study: This review aims to analyze environmental and socioeconomic factors influencing the global prevalence and transmission dynamics of these infections.Material and methods: A comprehensive English-language literature review was conducted using PubMed, Scopus, and the World Health Organization databases, focusing on articles published between January 1, 2012, and May 28, 2025. From an initial pool of 437 articles, 44 articles and 8 reports were included for detailed analysis.Results: Environmental determinants such as inadequate sanitation, poor water quality, and overcrowding significantly contribute to HAV and HEV outbreaks, particularly in low-income countries. Socioeconomic factors, including poverty, limited healthcare access, and education gaps, exacerbate HBV and HCV spread via unsafe medical practices and needle sharing. Displacement and migration amplify the vulnerability of at-risk populations, especially in regions with endemic viral hepatitis. Innovative technologies, including direct-acting antivirals for HCV and vaccines like Hecolin for HEV, have shown promise but face challenges in accessibility and affordability.Conclusions: This study underscores the critical connection of environmental and socioeconomic factors in shaping the burden of hepatotropic viruses globally. Targeted public health interventions, improved healthcare access, and policy frameworks are essential to reduce transmission and achieve WHO's 2030 elimination targets for HBV and HCV.
- 24 June 2025
- Published by Index Copernicus in Medical Science Pulse
Environmental and socioeconomic factors influencing hepatotropic virus transmission
Background: Viral hepatitis remains a major public health concern worldwide. In 2022 alone, it accounted for approximately 1.3 million deaths, with hepatitis B (HBV) and hepatitis C viruses (HCV) responsible for the majority. However, hepatitis A (HAV) and hepatitis E (HEV) viruses continue to cause significant outbreaks, especially in settings with poor sanitation, while hepatitis D virus contributes to more severe outcomes in individuals with HBV. The burden of these infections is disproportionately high in low- and middle-income countries, where socioeconomic disparities, environmental conditions, and healthcare limitations hinder prevention and control efforts. Aims of the study: This review aims to analyze environmental and socioeconomic factors influencing the global prevalence and transmission dynamics of these infections.Material and methods: A comprehensive English-language literature review was conducted using PubMed, Scopus, and the World Health Organization databases, focusing on articles published between January 1, 2012, and May 28, 2025. From an initial pool of 437 articles, 44 articles and 8 reports were included for detailed analysis.Results: Environmental determinants such as inadequate sanitation, poor water quality, and overcrowding significantly contribute to HAV and HEV outbreaks, particularly in low-income countries. Socioeconomic factors, including poverty, limited healthcare access, and education gaps, exacerbate HBV and HCV spread via unsafe medical practices and needle sharing. Displacement and migration amplify the vulnerability of at-risk populations, especially in regions with endemic viral hepatitis. Innovative technologies, including direct-acting antivirals for HCV and vaccines like Hecolin for HEV, have shown promise but face challenges in accessibility and affordability.Conclusions: This study underscores the critical connection of environmental and socioeconomic factors in shaping the burden of hepatotropic viruses globally. Targeted public health interventions, improved healthcare access, and policy frameworks are essential to reduce transmission and achieve WHO's 2030 elimination targets for HBV and HCV.
- 31 March 2025
- Published by Index Copernicus in Medical Science Pulse
The association between cardiovascular complications of chronic hepatotropic viral infection: a narrative review of pathophysiological pathways
BackgroundChronic hepatotropic viral infections are a global health burden due to their prevalence and systemic impacts. Usually associated with hepatic complications, new evidence indicates that these infections also contribute to cardiovascular diseases (CVD). The mechanisms underlying these associations involve direct viral effects, chronic inflammation, immune dysregulation, and metabolic alterations.Aim of the StudyThis review aims to explore the pathophysiological mechanisms by which chronic hepatotropic viral infections influence cardiovascular health, assess the clinical implications and highlight strategies for managing cardiovascular risks.Material and MethodsA literature review was conducted using the search terms Hepatitis B AND cardiovascular disease, Hepatitis C AND cardiovascular risk, Hepatitis D AND atherosclerosis, Hepatitis E AND cardiac complications, Chronic viral hepatitis AND myocardial infarction on PubMed (articles published from January 1, 2009 through January 1, 2025), National Institutes of Health (NIH) (articles published from January 1, 2009 through January 1, 2025), and the World Health Organization (WHO) data.ResultsHepatitis C virus contributes significantly to atherosclerosis through endothelial dysfunction and chronic inflammation. For hepatitis B virus (HBV), the association with CVD remains inconclusive. Some studies suggest that HBV promotes oxidative stress and macrophage phenotypic changes conducive to atherosclerosis, others report no cardiovascular impact. Hepatitis D virus coinfection amplifies systemic inflammation, inducing cytokine storms and exacerbating vascular damage. Hepatitis E virus has been linked to arrhythmias, thrombosis, and endothelial dysfunction in immunocompromised patients.ConclusionsHepatotropic viral infections pose risks to cardiovascular health through direct and indirect mechanisms. Antiviral therapies have transformed the management of HCV and HBV, but their cardiovascular implications necessitate monitoring and intervention strategies. Screening, effective antiviral treatment, and targeted lifestyle modifications are critical for mitigating cardiovascular risks.
- 31 March 2025
- Published by Index Copernicus in Medical Science Pulse
The association between cardiovascular complications of chronic hepatotropic viral infection: a narrative review of pathophysiological pathways
BackgroundChronic hepatotropic viral infections are a global health burden due to their prevalence and systemic impacts. Usually associated with hepatic complications, new evidence indicates that these infections also contribute to cardiovascular diseases (CVD). The mechanisms underlying these associations involve direct viral effects, chronic inflammation, immune dysregulation, and metabolic alterations.Aim of the StudyThis review aims to explore the pathophysiological mechanisms by which chronic hepatotropic viral infections influence cardiovascular health, assess the clinical implications and highlight strategies for managing cardiovascular risks.Material and MethodsA literature review was conducted using the search terms Hepatitis B AND cardiovascular disease, Hepatitis C AND cardiovascular risk, Hepatitis D AND atherosclerosis, Hepatitis E AND cardiac complications, Chronic viral hepatitis AND myocardial infarction on PubMed (articles published from January 1, 2009 through January 1, 2025), National Institutes of Health (NIH) (articles published from January 1, 2009 through January 1, 2025), and the World Health Organization (WHO) data.ResultsHepatitis C virus contributes significantly to atherosclerosis through endothelial dysfunction and chronic inflammation. For hepatitis B virus (HBV), the association with CVD remains inconclusive. Some studies suggest that HBV promotes oxidative stress and macrophage phenotypic changes conducive to atherosclerosis, others report no cardiovascular impact. Hepatitis D virus coinfection amplifies systemic inflammation, inducing cytokine storms and exacerbating vascular damage. Hepatitis E virus has been linked to arrhythmias, thrombosis, and endothelial dysfunction in immunocompromised patients.ConclusionsHepatotropic viral infections pose risks to cardiovascular health through direct and indirect mechanisms. Antiviral therapies have transformed the management of HCV and HBV, but their cardiovascular implications necessitate monitoring and intervention strategies. Screening, effective antiviral treatment, and targeted lifestyle modifications are critical for mitigating cardiovascular risks.